Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
CROSS-LINKING AGENT B-lymphocyte antigen CD20 cross-linking agent PubMed

Cross References

Resources Reference
ChEMBL CHEMBL2109351